公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2020 | miR-146b-5p Enhances the Sensitivity of NSCLC to EGFR Tyrosine Kinase Inhibitors by Regulating the IRAK1/NF-κB Pathway | Liu, Yi-Nan; Tsai, Meng-Feng; SHANG-GIN WU ; Chang, Tzu-Hua; TZU-HSIU TSAI ; Gow, Chien-Hung; Wang, Hsin-Yi; JIN-YUAN SHIH | Molecular therapy. Nucleic acids | 25 | 26 | |
2020 | MiR-200c-3p suppression is associated with development of acquired resistance to epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors in EGFR mutant non-small cell lung cancer via a mediating epithelial-to-mesenchymal transition (EMT) process | Wang, Hsin-Yi; Liu, Yi-Nan; SHANG-GIN WU ; HSU, CHIA-LANG ; Chang, Tzu-Hua; Tsai, Meng-Feng; YEN-TING LIN ; JIN-YUAN SHIH | Cancer biomarkers : section A of Disease markers | 25 | 20 | |
2024 | miR-204 suppresses cancer stemness and enhances osimertinib sensitivity in non-small cell lung cancer by targeting CD44 | SHANG-GIN WU ; Chang, Tzu-Hua; Tsai, Meng-Feng; Liu, Yi-Nan; YEN-LIN HUANG ; Hsu, Chia-Lang; Jheng, Han-Nian; JIN-YUAN SHIH | Molecular therapy. Nucleic acids | | | |
2023 | MiR-503 pleiotropically regulates epithelial-mesenchymal transition and targets PTK7 to control lung cancer metastasis | TZU-HSIU TSAI ; Gow, Chien-Hung; Liu, Yi-Nan; Tsai, Meng-Feng; Chang, Tzu-Hua; SHANG-GIN WU ; MIN-SHU HSIEH ; KANG-YI SU ; JIN-YUAN SHIH | Cancer medicine | 0 | 0 | |
2008 | Modulation of the expression of the invasion-suppressor CRMP-1 by cyclooxygenase-2 inhibition via reciprocal regulation of Sp1 and C/EBPα | Wu C.-C.; Lin J.-C.; Yang S.-C.; Lin C.-W.; Chen J.J.W.; JIN-YUAN SHIH ; Hong T.-M.; PAN-CHYR YANG | Molecular Cancer Therapeutics | 16 | 16 | |
2021 | Monitoring levels of vimentin-positive circulating cancer stem cells and tumor cells in patients with advanced EGFR-mutated non-small cell lung cancer | CHIA-LIN HSU ; TZU-HSIU TSAI ; CHUN-KAI HUANG ; CHING-YAO YANG ; WEI-YU LIAO ; CHAO-CHI HO ; SHENG-YUAN RUAN ; KUAN-YU CHEN ; JIN-YUAN SHIH ; PAN-CHYR YANG | Lung cancer (Amsterdam, Netherlands) | 5 | 5 | |
2022 | Multi-energy level fusion for nodal metastasis classification of primary lung tumor on dual energy CT using deep learning | Wang, You-Wei; Chen, Chii-Jen; Wang, Teh-Chen; Huang, Hsu-Cheng; HSIN-MING CHEN ; JIN-YUAN SHIH ; JIN-SHING CHEN ; YU-SEN HUANG ; YEUN-CHUNG CHANG ; RUEY-FENG CHANG | Computers in Biology and Medicine | 7 | 4 | |
2013 | Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopy | TZU-HSIU TSAI ; CHING-YAO YANG ; CHAO-CHI HO ; WEI-YU LIAO ; I-SHIOW JAN ; KUAN-YU CHEN ; JANN-YUAN WANG ; SHENG-YUAN RUAN ; CHONG-JEN YU ; CHIH-HSIN YANG ; PAN-CHYR YANG ; JIN-YUAN SHIH | Lung Cancer | 33 | 30 | |
2021 | Multi-kinase framework promotes proliferation and invasion of lung adenocarcinoma through activation of dynamin-related protein 1 | KUEI-PIN CHUNG ; YEN-LIN HUANG ; Chen, Yi-Jung; Juan, Yi-Hsiu; Hsu, Chia-Lang ; Nakahira, Kiichi; Huang, Yen-Tsung; MONG-WEI LIN ; SHANG-GIN WU ; JIN-YUAN SHIH ; YIH-LEONG CHANG ; CHONG-JEN YU | Molecular Oncology | 10 | 8 | |
2014 | Multidriver mutation analysis in pulmonary mucinous adenocarcinoma in Taiwan: Identification of a rare CD74-NRG1 translocation case | Gow C.-H.; SHANG-GIN WU ; YIH-LEONG CHANG ; JIN-YUAN SHIH | Medical Oncology | 24 | 21 | |
2017 | Multiple Acquired Resistance Mutations of the ALK Tyrosine Kinase Domain after Sequential Use of ALK Inhibitors | Wang H.-Y.; CHAO-CHI HO ; JIN-YUAN SHIH | Journal of Thoracic Oncology | 9 | 7 | |
2013 | Neoadjuvant chemotherapy with docetaxel-cisplatin in patients with stage III N2 non-small-cell lung cancer | WEI-YU LIAO ; Chen J.-H.; Wu M.; JIN-YUAN SHIH ; KUAN-YU CHEN ; CHAO-CHI HO ; CHIH-HSIN YANG ; CHONG-JEN YU | Clinical Lung Cancer | 22 | 20 | |
2002 | New aspects in clinicopathologic and oncogene studies of 23 pulmonary lymphoepithelioma-like carcinomas | YIH-LEONG CHANG ; CHEN-TU WU ; JIN-YUAN SHIH ; Lee Y.-C. | American Journal of Surgical Pathology | 104 | 84 | |
2019 | Non-small cell lung cancer harbouring non-resistant uncommon EGFR mutations: Mutation patterns, effectiveness of epidermal growth factor receptor-tyrosine kinase inhibitors and prognostic factors | LIH-CHYUN CHANG ; Lim, Chor-Kuan; LIH-YU CHANG ; KUAN-YU CHEN ; JIN-YUAN SHIH ; CHONG-JEN YU | European Journal of Cancer | 21 | 19 | |
1997 | Nontuberculous mycobacteria isolates: Clinical significance and disease spectrum | JIN-YUAN SHIH ; PO-REN HSUEH ; LI-NA LEE ; HAO-CHIEN WANG ; PAN-CHYR YANG ; Kuo S.-H.; KWEN-TAY LUH | Journal of the Formosan Medical Association | 34 | 28 | |
2020 | Not All EGFR Exon 20 Insertions Are Created Equal | YEN-TING LIN ; JIN-YUAN SHIH | JTO clinical and research reports | 2 | 0 | |
2005 | Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway | Lo H.-W.; Hsu S.-C.; Ali-Seyed M.; Gunduz M.; Xia W.; Wei Y.; Bartholomeusz G.; JIN-YUAN SHIH ; Hung M.-C. | Cancer Cell | 432 | 396 | |
2020 | An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan | SHANG-GIN WU ; Chiang, Chi-Lu; Liu, Chien-Ying; Wang, Chin-Chou; Su, Po-Lan; Hsia, Te-Chun; JIN-YUAN SHIH ; Chang, Gee-Chen | Frontiers in Oncology | 23 | 23 | |
2022 | An Observational Study on Treatment Outcomes in Patients With Stage III NSCLC in Taiwan: The KINDLE Study | Su P.-L.; Chang G.-C.; Hsiao S.-H.; Hsia T.-C.; Lin M.-C.; Lin M.-H.; JIN-YUAN SHIH ; Yang C.-T.; Yang S.-H.; Chen Y.-M. | JTO Clinical and Research Reports | 2 | 0 | |
2010 | Octogenarians with advanced non-small cell lung cancer: Treatment modalities, survival, and prognostic factors | KUAN-YU CHEN ; JEN-HAU CHEN ; JIN-YUAN SHIH ; CHIH-HSIN YANG ; CHONG-JEN YU ; PAN-CHYR YANG | Journal of Thoracic Oncology | 17 | 14 | |